Dr. Anna E. Bortnick, MD, PhD

Dr. Bortnick practices at Montefiore Medical Center in Bronx, New York.

Dr. Bortnick's NPI, 1346391869, was assigned on January 12, 2007. Dr. Bortnick graduated from Drexel University College of Medicine/Hahnemann University in 2005. Dr. Bortnick holds New York license 265384-1.

Dr. Bortnick's primary practice is Montefiore Medical Center, at 1250 Waters Pl, Bronx, NY 10461 in Bronx County. The practice phone is (718) 920-2966.

Dr. Bortnick's primary practice is Montefiore Medical Center in Bronx, New York. Dr. Bortnick is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Bortnick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bortnick practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bortnick's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bortnick is licensed in New York.

CMS data shows 199 Medicare services from Dr. Bortnick across 7 procedure codes in 2024, for 94 Medicare patients. Medicare paid $28,436 for them.

CMS counts 94 Medicare patients who saw Dr. Bortnick in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bortnick's median patient age at 72, with 52% women.

In 2024, Dr. Bortnick wrote 797 Medicare Part D claims for 90 patients. 78% of them were for generic drugs. CMS names the drug for 676 of them, across 21 drugs with 11 or more claims each, at $155,413 in total drug cost. In 2023, CMS named 526 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bortnick for performance year 2024, reported as part of a group. CMS counts 23 procedures of coronary angioplasty and stenting by Dr. Bortnick, more than 55% of the clinicians it reports for that procedure.

Dmand AI links 61 papers to Dr. Bortnick, published from 2012 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Aortic Valve Stenosis, Aortic Valve and Percutaneous Coronary Intervention. Dr. Bortnick has published most often in Catheter Cardiovasc Interv. Dr. Bortnick's most frequent co-authors are Jorge R. Kizer, MD, Mark A. Menegus, MD and Jose M. Wiley, MD.

Dmand AI links Dr. Bortnick to 1 clinical trial. Conditions studied include Coronary Restenosis and Coronary Stenosis.

CMS Open Payments shows 61 general payments to Dr. Bortnick from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $1,019.

Dr. Bortnick graduated from Drexel University College of Medicine/Hahnemann University in 2005.